NCT03901235View on ClinicalTrials.gov

MSC Intratissular Injection in Crohn Disease Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Efficacy and Safety
Interventions
BIOLOGICAL

Mesenchymal Stromal Cells

Suspension of mesenchymal stromal cells for intratissular injection

Trial Locations (1)

4000

RECRUITING

CHU de Liège, Liège

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Liege

OTHER

lead

University of Liege

OTHER